Based on the granzyme ratio between granzyme A and granzyme B, we have observed that COVID-19 patients with non-severe forms of the disease presented a higher capacity for granzyme A secretion and a lower capacity for granzyme B secretion, contrary to their severe counterparts. The gene discussed is GZMB; the disease is COVID-19.